Skip to main content

and
  1. No Access

    Article

    Effect of verapamil on doxorubicin activity and pharmacokinetics in mice bearing resistant and sensitive solid tumors

    The effect of the combined administration of verapamil (i.p. twice daily) and doxorubicin (i.v once weekly) was tested in mice bearing the following: (a) a tumor with induced resistance to doxorubicin (B16VDXR...

    Franca Formelli, Loredana Cleris, Roberto Carsana in Cancer Chemotherapy and Pharmacology (1988)

  2. No Access

    Article

    Postsurgical adjuvant chemoimmunotherapy with recombinant interleukin-2 and 1,3-bis-(2-chloroethyl)-1-nitrosurea on spontaneous metastases of a non-immunogenic murine tumour

    The efficacy of the association of recombinant interleukin-2 (rIL-2) with chemotherapy has been investigated on an experimental model representative of clinical tumours, i.e. on post-surgical spontaneous metas...

    Giulia Acerbis, Loredana Cleris, Monica Rodolfo in Cancer Immunology, Immunotherapy (1992)

  3. No Access

    Article

    Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation

    The TRK-T3 oncoprotein, isolated from a human papillary thyroid tumor, arises from the fusion between the N-terminal domain of the TFG gene and the tyrosine kinase domain of the NTRK1 receptor. The 68 kDa TRK-...

    Emanuela Roccato, Sonia Pagliardini, Loredana Cleris, Silvana Canevari in Oncogene (2003)

  4. No Access

    Article

    Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34+ cells

    The proapoptotic death receptor 5 (DR5) expressed by tumor associated endothelial cells (TECs) mediates vascular disrupting effects of human CD34+ cells engineered to express membrane-bound tumor necrosis factor-...

    Arianna Giacomini, Marco Righi, Loredana Cleris, Silvia L. Locatelli in Angiogenesis (2013)

  5. Article

    Open Access

    Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients

    Progression to stage IV disease remains the main cause of breast cancer-related deaths. Increasing knowledge on the hematogenous phase of metastasis is key for exploiting the entire window of opportunity to in...

    Emanuela Fina, Loredana Cleris, Matteo Dugo in Journal of Experimental & Clinical Cancer … (2022)